filgotinib

Doctors like AbbVie's Rinvoq in IBD, but not Bristol's Zeposia

Among a list of five novel oral agents for inflammatory bowel disease, physicians ranked Rinvoq as their favorite and Zeposia the least attractive.

Angus Liu Feb 22, 2021 11:17am

Gilead guts its filgotinib plans—and CEO's rebuild along with it

Dec 16, 2020 10:54am

CStone-Pfizer, Gilead, Takeda-Ovid and more—FiercePharmaAsia

Oct 2, 2020 9:10am

Gilead's RA drug filgotinib wins global-first nod in Japan

Sep 25, 2020 11:18am

AbbVie's JAK med Rinvoq stands to gain from Gilead's FDA setback

Aug 20, 2020 8:11am

Gilead leans on data, focus to launch filgotinib in crowded RA

Jan 21, 2020 10:33am